- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT06057181
Rede de pesquisa Helix (HRN)
The Helix Research Network ("HRN") is a network of academic, public, and/or private healthcare organizations that are committed to advancing medical research and improving human health through large-scale genomics research and acceleration of the integration of genomic and other multi-omics data into clinical care.
Visão geral do estudo
Status
Intervenção / Tratamento
Descrição detalhada
The network will create a large-scale clinicogenomics dataset, which will support research to discover molecular and genetic determinants of disease risk, disease progression, treatment response, health economic outcomes, social or behavioral determinants of health, targets for therapeutic intervention, risk stratification, clinical implementation, and other clinical indicators of interest. This clinicogenomics dataset will be used to reveal molecular and/or genetic factors that could improve the diagnosis or medical treatment of individual participants and includes a process to share individual results with participants. Participants will also receive annual reports on study outcomes and the impact of HRN, as such information becomes available.
Institutional membership in HRN will consist of Helix and member healthcare systems (herein referred to as "HRN Member Site(s)"). The Helix Research Network is a multi-center research program that will enroll an unlimited number of participants. Participants will be recruited concurrently from HRN Member Sites. In some cases, HRN Member Sites may recruit participants from multiple clinical sites. Participants who meet the enrollment criteria established in this protocol will be enrolled if they or their legally authorized representative(s) provide informed consent in accordance with all applicable regulations and sIRB requirements. Participants will be enrolled until withdrawal from the study or end of the study. Participants may be recruited at any point during the study period, until the recruitment goals established by the protocol are met.
Tipo de estudo
Inscrição (Estimado)
Contactos e Locais
Contato de estudo
- Nome: Layla Anderson
- Número de telefone: 206-295-8866
- E-mail: researchadmin@helix.com
Locais de estudo
-
-
Indiana
-
Fort Wayne, Indiana, Estados Unidos, 46845
- Recrutamento
- Parkview Health (DNA Insights)
-
Contato:
- Jamie Renbarger, MD, MS
- Número de telefone: 260-266-9950
- E-mail: DNAInsights@parkview.com
-
-
Minnesota
-
Bloomington, Minnesota, Estados Unidos, 55425
- Recrutamento
- HealthPartners (myGenetics)
-
Contato:
- Douglas Olson, MD
- Número de telefone: 952-967-5357
- E-mail: mygenetics@healthpartners.com
-
Investigador principal:
- Douglas Olson, MD
-
-
Nebraska
-
Omaha, Nebraska, Estados Unidos, 68198
- Recrutamento
- Nebraska Medicine - University of Nebraska Medical Center (Genetic Insights Project)
-
Contato:
- Serena Gaines
- Número de telefone: 402-559-1350
- E-mail: Geneticinsights@NebraskaMed.com
-
Investigador principal:
- Douglas Stoller, MD, PhD
-
-
Nevada
-
Reno, Nevada, Estados Unidos, 89502
- Recrutamento
- Renown Health (Healthy Nevada Project)
-
Contato:
- Savanna Grime, MPH
- Número de telefone: 775-982-7995
- E-mail: savanna.grime@renown.org
-
Investigador principal:
- Joseph Grzymski, MD
-
-
New York
-
Rochester, New York, Estados Unidos, 14621
- Recrutamento
- Rochester Regional Health (GenoWell)
-
Contato:
- Heather R Bacchetta
- Número de telefone: (585) 922-4366
- E-mail: GenoWell@rochesterregional.org
-
Investigador principal:
- Pradyumna Phatak, MD
-
-
North Carolina
-
Burlington, North Carolina, Estados Unidos, 27401
- Recrutamento
- Cone Health (Gene Connect)
-
Contato:
- Alison Sigmon, PhD
- Número de telefone: 336.890.2999
- E-mail: geneconnect@conehealth.com
-
Investigador principal:
- Chad Haldeman-Englert, MD
-
Raleigh, North Carolina, Estados Unidos, 27610
- Recrutamento
- WakeMed (PreciselyYou)
-
Contato:
- Casey Granack
- E-mail: preciselyyou@wakemed.org
-
Investigador principal:
- William Legarde, MD
-
-
Ohio
-
Cincinnati, Ohio, Estados Unidos, 45202
- Recrutamento
- TriHealth (DNA Discovery)
-
Investigador principal:
- James Maher, MD
-
Contato:
- Courtney Rice
- Número de telefone: (513) 862-9954
- E-mail: DNADiscovery@TriHealth.com
-
Columbus, Ohio, Estados Unidos, 43210
- Recrutamento
- The Ohio State University (Genomic Health)
-
Contato:
- Hannah Beasley
- Número de telefone: 614-366-GENE (4363)
- E-mail: genomichealth@osumc.edu
-
Investigador principal:
- Amy Sturm, MS
-
-
Pennsylvania
-
Bethlehem, Pennsylvania, Estados Unidos, 18015
- Recrutamento
- St. Luke's University Health Network (DNAanswers)
-
Contato:
- Jean Reinert
- Número de telefone: 484-658-6300
- E-mail: DNAanswers@sluhn.org
-
Investigador principal:
- Christopher Chapman, MD
-
York, Pennsylvania, Estados Unidos, 17403
- Recrutamento
- WellSpan Health (The Gene Health Project)
-
Contato:
- Rebecca Eberly, BSN
- Número de telefone: 717-356-5395
- E-mail: reberly2@wellspan.org
-
Investigador principal:
- C.Anwar Chahal, MD,PhD
-
-
South Carolina
-
Charleston, South Carolina, Estados Unidos, 29425
- Recrutamento
- Medical University of South Carolina (In Our DNA SC)
-
Investigador principal:
- Daniel Judge, MD
-
Contato:
- Samantha Norman, MPH
- Número de telefone: 843-876-0582
- E-mail: inourdnasc@musc.edu
-
-
South Dakota
-
Sioux Falls, South Dakota, Estados Unidos, 57105
- Recrutamento
- Sanford Health (Imagine You)
-
Contato:
- Grace Beuch
- Número de telefone: (888) 424-2332
- E-mail: imageneticsinfo@sanfordhealth.org
-
Investigador principal:
- Stephen Powell, MD
-
-
Texas
-
Houston, Texas, Estados Unidos, 77030
- Recrutamento
- Memorial Hermann Health System (genoME)
-
Contato:
- Misty Ottman, BSN
- Número de telefone: 713-704-5610
- E-mail: Misty.Ottman@memorialhermann.org
-
Investigador principal:
- James McCarthy, MD
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
The study will recruit the general population from the surrounding areas of the HRN Member Sites. This may include patients within a health system of the Site or community members in the surrounding area of Sites.
Descrição
Inclusion Criteria:
- 18 years and older
- Willing and able to comply with all aspects of the protocol
Exclusion Criteria:
- History of allogenic bone marrow transplant
- History of allogenic stem cell transplant
- Anything that would place the individual at increased risk or preclude an individual's: 1) full compliance with study requirements; or 2) completion of the study based on the assessment from local consenting and enrolling Investigators.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Modelos de observação: ECOLOGIC_OR_COMMUNITY
- Perspectivas de Tempo: OTHER
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Establish a Research Network
Prazo: Through study completion, average 10 years
|
Establish a research network to support the advancement of biomedical research, improve human health through genomics research, and accelerate integration of genomic and other omics data into clinical care. |
Through study completion, average 10 years
|
|
Aggregate data
Prazo: Through study completion, average 10 years
|
Aggregate molecular, genomic data, phenotypic and other health-related data in centralized and/or federated databases to be accessed by investigators for approved research purposes. |
Through study completion, average 10 years
|
|
Re-Contact participants
Prazo: Through study completion, average 10 years
|
Recontact participants for additional data collection, research participation opportunities, and return of results |
Through study completion, average 10 years
|
|
Genetic biomarker identification
Prazo: Through study completion, average 10 years
|
Identification and characterization of clinical, histological, molecular, and genetic biomarkers that are linked to disease, disease outcomes, or that might be used to improvise disease classification. |
Through study completion, average 10 years
|
|
Exploration of genetic determinants of disease
Prazo: Through study completion, average 10 years
|
Exploration of the molecular and genetic underpinnings and determinants of disease, including disease risk, disease progression, treatment response, health economic outcomes, social or behavioral determinants of health, targets for therapeutic intervention, risk stratification, and other clinical indicators of interest. |
Through study completion, average 10 years
|
|
Collection and analysis of Patient Reported Outcomes
Prazo: Through study completion, average 10 years
|
Collection and analysis of Patient Reported Outcomes (e.g. quality of life, physical function, symptom burden) associated with diseases that have a genetic or molecular etiology. Validation of disease-specific instruments to assess the impact of genetic screening. |
Through study completion, average 10 years
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: William Lee, PhD, Helix, Inc
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- HRN 001
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
As a population health research network, the primary purpose of HRN is to help researchers and clinicians better understand how genetic information may be used to improve the health of individuals and communities. It is possible that participants may receive actionable health information as a result of analysis of their DNA information. This means that the participant's genetic results may be used by their healthcare providers to inform medical decisions. It is also possible that novel discoveries may be generated from the research that could positively impact a participant's healthcare in the future.
Prazo de Compartilhamento de IPD
Data will be available for the duration of the study.
Critérios de acesso de compartilhamento IPD
An application to the Helix Research Network or a Member Site for Member Site level data.
Tipo de informação de suporte de compartilhamento de IPD
- CIF
- CSR
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .